[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351432-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351432-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","subtype-stratified-consensus-gene-signatures-bridging-tumor-cell-biology-immune-microenvironment-and-clinical-prognosis-in-breast-cancer","Subtype-Stratified Consensus Gene Signatures: Bridging Tumor Cell Biology, Immune Microenvironment, and Clinical Prognosis in Breast Cancer","","Breast cancer shows profound molecular heterogeneity, limiting the clinical value of universal prognostic models. This study uses unsupervised clustering of transcriptomic data from three independent cohorts (TCGA, METABRIC, SCAN-B) to derive pan-cancer and PAM50 subtype-specific consensus prognostic gene signatures. ssGSEA-based prognostic scores stratify overall survival across cohorts and outperform established features by C-index, time-dependent AUC, NRI, and IDI. Enrichment and immune deconvolution reveal subtype-dependent mechanisms linking tumor cell programs with immune microenvironment composition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/subtype-stratified-consensus-gene-signatures-bridging-tumor-cell-biology-immune-microenvironment-and-clinical-prognosis-in-breast-cancer/351432/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/subtype-stratified-consensus-gene-signatures-bridging-tumor-cell-biology-immune-microenvironment-and-clinical-prognosis-in-breast-cancer/351432.png","ImageObject",300,407,{"name":42,"@type":43},"Riley West","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are universal prognostic tools insufficient for breast cancer?","Question",{"text":63,"@type":64},"Breast cancer is marked by extensive molecular heterogeneity, so models built on unstratified data do not capture subtype-specific biology and may misclassify patient risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the consensus prognostic gene signatures derived?",{"text":68,"@type":64},"Transcriptomic profiles from TCGA, METABRIC, and SCAN-B were clustered to identify pan-cancer and PAM50 subtype-specific consensus signatures, followed by cross-cohort validation using survival statistics and intersection of results.",{"name":70,"@type":61,"acceptedAnswer":71},"What biological link does the study propose between gene signatures and prognosis?",{"text":72,"@type":64},"Subtype-specific gene sets show functional enrichment and correlate with tumor-infiltrating immune cell proportions, connecting tumor cell programs with the tumor immune microenvironment and patient outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351432,1790523846,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nSubtype-Stratified Consensus Gene Signatures: Bridging Tumor Cell Biology, Immune Microenvironment, and Clinical Prognosis in Breast Cancer  \nXiaoqin Liu 1,2,3 and Shang Cai 2,3,4, *  \nAcademic Editors: Peter J. K. Kuppen and Jyoti Kaushal  \nReceived: 5 February 2026  \nRevised: 12 March 2026  \nAccepted: 29 March 2026  \nPublished: 31 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 School of Life Sciences, Zhejiang University, Hangzhou 310058, China; [liuxiaoqin@westlake.edu.cn](liuxiaoqin@westlake.edu.cn)  \n2 School of Life Sciences, Westlake University, Hangzhou 310024, China  \n3 Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University, Hangzhou 310024, China  \n4 Westlake Disease Modeling Lab, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China  \n* Correspondence: [caishang@westlake.edu.cn](caishang@westlake.edu.cn)  \nAbstract  \nBreast cancer is characterized by profound molecular heterogeneity, which severely limits the clinical utility of universal prognostic tools. To address this gap, we systematically explored transcriptomic profiles in three independent breast cancer cohorts (TCGA, METABRIC, and SCAN-B) via unsupervised clustering. We identified both pan-cancer and PAM50 subtype-specific consensus prognostic gene signatures through log-rank tests and cross-cohort intersection. Single-sample Gene Set Enrichment Analysis (ssGSEA)-derived prognostic scores strongly stratified overall survival across all cohorts, with superior performance over established features (assessed via C-index, time-dependent AUC, NRI, and IDI) . Functional enrichment analysis uncovered subtype-specific biological mechanisms: immune-related pathways dominated good-prognostic gene sets in HER2-enriched and Basal-like tumors, while oncogenic pathways characterized poor-prognostic gene sets. Correlation analysis with CIBERSORT-deconvolved immune cell proportions revealed that good-prognostic scores positively correlated with anti-tumor immune cells (CD8+ T cells, M1 macrophages) and negatively with pro-tumor cells (M2 macrophages, Tregs) . Independent validation in the Lancet2005 ER+ cohort confirmed that Luminal prognostic gene sets robustly stratified distant relapse-free survival. Collectively, these subtype-specific consensus signatures integrate tumor cell biology and tumor immune microenvironment features, offering robust prognostic tools with potential for future clinical translation.  \nKeywords: breast cancer; PAM50 subtype; subtype-specific prognostic gene signature; tumor immune microenvironment (TIME); pathway enrichment  \n1. Introduction  \nBreast cancer remains the most prevalent malignancy among women worldwide, with substantial mortality driven by its inherent molecular heterogeneity [1–4] . The PAM50 classification system has revolutionized breast cancer management by identifying five distinct subtypes (Luminal A, Luminal B, HER2-enriched, Basal-like, and Normal-like) with unique clinical outcomes and therapeutic responses [1–4] . For example, Luminal A tumors exhibit indolent behavior and sensitivity to endocrine therapy, while Basal-like/triplenegative breast cancer (TNBC) is aggressive and lacks targeted treatment options [5] .  \nDespite this progress, conventional prognostic factors (e.g., tumor size, lymph node status, grade) fail to capture the molecular complexity underlying variable outcomes within subtypes, leading to overtreatment of low-risk patients and undertreatment of high-risk individuals [6,7] .  \nPrognostic gene signatures have emerged as promising complements to clinical factors, but most existing signatures are derived from unstratified cohorts, ignoring subtype-specific biology [8,9] . This “one-size-fits-all” approach limits their generalizability: signatures effective f","cbCaitZxacASHxS4","https://ap.wps.com/l/cbCaitZxacASHxS4","pdf",10133053,21,"English","# Introduction\n## Background: molecular heterogeneity and PAM50 subtypes\n## Limitations of conventional prognostic factors\n## Need for consensus, subtype-specific gene signatures\n## Role of the tumor immune microenvironment (TIME)\n# Study aims","[{\"question\":\"Why are universal prognostic tools insufficient for breast cancer?\",\"answer\":\"Breast cancer is marked by extensive molecular heterogeneity, so models built on unstratified data do not capture subtype-specific biology and may misclassify patient risk.\"},{\"question\":\"How were the consensus prognostic gene signatures derived?\",\"answer\":\"Transcriptomic profiles from TCGA, METABRIC, and SCAN-B were clustered to identify pan-cancer and PAM50 subtype-specific consensus signatures, followed by cross-cohort validation using survival statistics and intersection of results.\"},{\"question\":\"What biological link does the study propose between gene signatures and prognosis?\",\"answer\":\"Subtype-specific gene sets show functional enrichment and correlate with tumor-infiltrating immune cell proportions, connecting tumor cell programs with the tumor immune microenvironment and patient outcomes.\"}]","Subtype-Stratified Consensus Gene Signatures: Bridging Tumor Cell Biology, Immune Microenvironment, and Clinical Prognosis in Breast Cancer | PDF",1790094139,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08efc9e4f9d93d1f8ebb0a5bf3c79666.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca29669eb8e0424c8be858fbb3a09271.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a76d0a0fca587485dd17f0575574448d.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e1c379f84d65a819649c4e0887957ee.webp",980,1385]